2-Acetylfuran CAS 1192-62-7 - China Factory, Suppliers, Manufacturers

2-Acetylfuran CAS 1192-62-7, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

2-Acetylfuran CAS 1192-62-7 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 2-Acetylfuran CAS 1192-62-7 (2-Furyl Methyl Ketone) Purity >99.0% (GC)
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...

2022.10.31 10:04:00
2022.07.28 11:07:56
2022.06.09 08:22:19
2022.05.18 19:31:55
2022.03.12 06:31:38
2021.12.29 06:19:05

2-Acetylfuran CAS 1192-62-7 - China Factory, Suppliers, Manufacturers

Related Products

2-Acetylfuran CAS 1192-62-7 (2-Furyl Methyl Ketone) Purity >99.0% (GC)

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

4-Fluoroaniline CAS 371-40-4 Purity >99.0% (GC)

(-)-Di-p-anisoyl-L-Tartaric Acid; L-DMTA CAS 50583-51-2 Purity ≥99.0% (HPLC) High Quality

1,4-Bis(trifluoromethyl)benzene CAS 433-19-2 Purity >99.0% (GC)

HEPES Sodium Salt CAS 75277-39-3 Purity >99.5% (Titration) Biological Buffer Ultra Pure Factory

2,3-Diphenylquinoxaline CAS 1684-14-6 Purity >98.0% (GC)

Ammonium Sulfate CAS 7783-20-2 Content 99.0~100.5%

Ganciclovir CAS 82410-32-0 API BW 759 GCV Antiviral CMV Inhibitor High Quality

L-Cysteic Acid CAS 498-40-8 H-Cys(O3H)-OH) Assay >98.0% (T)

2-(Benzylthio)nicotinic Acid CAS 112811-90-2 Purity >98.0% (HPLC) (T)

4-Aminoindole CAS 5192-23-4 Purity ≥99.0% (HPLC) Factory High Quality

4-Chlorophenethyl Alcohol CAS 1875-88-3 Purity >99.0% (GC)

6-Nitroveratric Acid CAS 4998-07-6 Purity >98.5% (HPLC)

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

New COVID treatments offer hope

Xi presents award to top scientists

Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

2022.10.31 10:04:00

2022.07.28 11:07:56

2022.06.09 08:22:19

2022.05.18 19:31:55

2022.03.12 06:31:38

2021.12.29 06:19:05

related search